Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sunil Badve

Showing results (91-100 of 206) with videos related to

Pageof 21
Sort By:
Breast Cancer Research and Treatment|January 27, 2022
Utility of Oncotype DX score in clinical management for T1 estrogen receptor positive, HER2 negative, and lymph node negative breast cancerThi Truc Anh Nguyen, Lauren M Postlewait, Chao Zhang, et al.
Journal of Clinical Pathology|July 30, 2013
EP1: a novel rabbit monoclonal antibody for detection of oestrogen receptor αSunil Badve, I Tudor Vladislav, Betsy Spaulding, et al.
Frontiers in Oncology|November 4, 2022
A phase II study of buparlisib in relapsed or refractory thymomasMohammad I Abu Zaid, Milan Radovich, Sandra Althouse, et al.
Breast Cancer Research and Treatment|January 4, 2011
The effects of oncotype DX recurrence scores on chemotherapy utilization in a multi-institutional breast cancer cohortFoluso O Ademuyiwa, Austin Miller, Tracey O'Connor, et al.
Molecular Biology of the Cell|November 17, 2006
NuMA influences higher order chromatin organization in human mammary epitheliumPatricia C Abad, Jason Lewis, I Saira Mian, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|February 18, 2020
Icodextrin use for peritoneal dialysis in Australia: A cohort study using Australia and New Zealand Dialysis and Transplant RegistryDharshan Rangaswamy, Vasudeva Guddattu, Angela C Webster, et al.
Breast Cancer Research and Treatment|October 23, 2012
Investigational drug MLN0128, a novel TORC1/2 inhibitor, demonstrates potent oral antitumor activity in human breast cancer xenograft modelsYesim Gökmen-Polar, Yi Liu, Rachel A Toroni, et al.
Human Pathology|February 21, 2008
Lymphatic vessel density in radical prostatectomy specimensLiang Cheng, Elena Bishop, Honghong Zhou, et al.
Carcinogenesis|January 29, 2005
The macrophage inhibitory cytokine integrates AKT/PKB and MAP kinase signaling pathways in breast cancer cellsWyatt Wollmann, Mike L Goodman, Poornima Bhat-Nakshatri, et al.
The Journal of Investigative Dermatology|April 28, 2005
Immunolocalization of low-affinity prostaglandin E receptors, EP and EP, in adult human epidermisRaymond L Konger, Steven D Billings, Angela B Thompson, et al.
Pageof 21

Showing results (91-100 of 206) with videos related to

Sort By:
Pageof 21
Breast Cancer Research and Treatment|January 27, 2022
Utility of Oncotype DX score in clinical management for T1 estrogen receptor positive, HER2 negative, and lymph node negative breast cancerThi Truc Anh Nguyen, Lauren M Postlewait, Chao Zhang, et al.
Journal of Clinical Pathology|July 30, 2013
EP1: a novel rabbit monoclonal antibody for detection of oestrogen receptor αSunil Badve, I Tudor Vladislav, Betsy Spaulding, et al.
Frontiers in Oncology|November 4, 2022
A phase II study of buparlisib in relapsed or refractory thymomasMohammad I Abu Zaid, Milan Radovich, Sandra Althouse, et al.
Breast Cancer Research and Treatment|January 4, 2011
The effects of oncotype DX recurrence scores on chemotherapy utilization in a multi-institutional breast cancer cohortFoluso O Ademuyiwa, Austin Miller, Tracey O'Connor, et al.
Molecular Biology of the Cell|November 17, 2006
NuMA influences higher order chromatin organization in human mammary epitheliumPatricia C Abad, Jason Lewis, I Saira Mian, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|February 18, 2020
Icodextrin use for peritoneal dialysis in Australia: A cohort study using Australia and New Zealand Dialysis and Transplant RegistryDharshan Rangaswamy, Vasudeva Guddattu, Angela C Webster, et al.
Breast Cancer Research and Treatment|October 23, 2012
Investigational drug MLN0128, a novel TORC1/2 inhibitor, demonstrates potent oral antitumor activity in human breast cancer xenograft modelsYesim Gökmen-Polar, Yi Liu, Rachel A Toroni, et al.
Human Pathology|February 21, 2008
Lymphatic vessel density in radical prostatectomy specimensLiang Cheng, Elena Bishop, Honghong Zhou, et al.
Carcinogenesis|January 29, 2005
The macrophage inhibitory cytokine integrates AKT/PKB and MAP kinase signaling pathways in breast cancer cellsWyatt Wollmann, Mike L Goodman, Poornima Bhat-Nakshatri, et al.
The Journal of Investigative Dermatology|April 28, 2005
Immunolocalization of low-affinity prostaglandin E receptors, EP and EP, in adult human epidermisRaymond L Konger, Steven D Billings, Angela B Thompson, et al.
Pageof 21